|
GREGORY
Q. MARSELLA, M.D., P.A. EMPLOYMENT January
2004 -Present Co-Founder, ThinkHealthy.org, Incorporated
Non-Profit Foundation for the improving care for those suffering from mental disorders
March 1997- Present
Co-Chairman and Founder, Health Sciences
A Medical Research Services Network April
1992 - Present Private Practice
July 1987-April 1992
Fair Oaks
Director of Adolescent Treatment Services
Medical Director of Adolescent Inpatient Unit
EDUCATION 1984-1987 New York Hospital-Cornell Medical Center,
White Plains,
Psychiatry Residency 1983-1984 New York Hospital-Payne Whitney;
New York Hospital-Westchester;
Memorial Hospital/Sloan-Kettering;
La Guardia Hospital
Internship 1978-1983 University Of
Doctor Of Medicine Degree 1971-1976 Harvard University
Cambridge,
B.A. Degree Cum Laude in English Literature; Thesis Rank: Magna Cum Laude
MEMBERSHIPS American Medical Association American Psychiatric
Association
LICENSURE DEA No. BM 1056731 DEA No. AM 3029825
BOARD CERTIFICATION Diplomate, American Board of
Psychiatry and Neurology, Certificate #42544 Diplomate, National Board of
Medical Examiners
ADMITTING PRIVILEGES
COVERAGE 24-Hour Coverage by
Voice-Mail/Emergency Beeper Vacation/Out-Of-Town
Same-Office Coverage by Anthony Yacona, MD and
MAJOR INTERESTS Adult and Geriatric
Psychiatry Depression and Anxiety
Disorders Psychopharmacology Psychoanalytic Psychotherapy Adolescent Psychiatry
ACTIVE,
CLOSED OR SITE SELECTED RESEARCH STUDIES: 1.
“An
open-label study of tolerability, clinical response, and satisfaction in adult
bipolar I subjects optimizing initiation of therapy using administration of
dermatological precautions and Lamictal titration packs.” 2.
“Lilly’s
emotional and physical symptoms of depression study (LEAPS).” 3.
“An
assessment of behavioral changes associated with Lamotrigine and Levetiracetam
in patients with epilepsy.” 4.
“Formal
observation of Concerta versus Strattera comparison of treatment outcomes in
children with ADHD.” 5.
“A
prospective, multi-center, open-label study of Aripiprazole in the management of
patients with schizophrenia or schizoaffective disorder in the general
psychiatric practices. “ 6.
“An
international, multi-center, large simple trial (LST) to compare the
cardiovascular safety of Ziprasidone and Olanzapine.” 7.
“Escitalopram effects on Quality of Life.” 8.
“Nefazadone in the treatment of
patients with chronic pain.” 9.
“A double-blind,
placebo-controlled, randomized clinical trial of the efficacy of Sertraline in
the treatment of dysthymia.” 10.
“Nefazadone in the treatment of
agitated geriatric patients.” 11.
“A placebo-controlled study of
Olanzapine monotherapy in the treatment of bipolar I depression.” 12.
“An open-label combination of
Olanzapine and Fluoxetine in major depressive disorder.” 13.
“A twelve-week, double-blind,
placebo-controlled, parallel group study to assess the efficacy and tolerability
of Paroxetine in patients suffering from Posttraumatic Stress Disorder (PTSD).” 14.
“A multi-center, randomized,
double-blind, placebo-controlled study of two doses of Aripiprazole in the
treatment of hospitalized patients with acute mania.” 15.
“A multi-center, open-label,
long-term study of the safety, tolerability and efficacy of Aripiprazole in the
maintenance treatment of patients with bipolar disorders.” 16.
“An open-label evaluation of
Lamotrigine versus Carbamapezine, Phenytoin, and Divalproex Sodium as
monotherapy treatment for epilepsy patients who have failed a previous course of
anti-epileptic drug therapy.” REFERENCES Furnished upon request
|
|
Copyright © 2005 ThinkHealthy™ All Rights Reserved. |